If you have been reading about Preclinical study and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-02-21. Where a claim depends on a specific study, the study is described rather than over-claimed.
Research on dihexa has primarily used rodent models and cultured cells. Common endpoints include dendritic spine density, synaptic protein expression, and performance on maze or avoidance tasks. Some studies report improvements in cognitive measures after scopolamine-induced deficits or in aged animals. These findings are interesting but come from a small body of work, and independent laboratories have not consistently replicated all reported effects. Larger, preregistered studies would help clarify which results are robust.
Human data for dihexa remain absent from peer-reviewed clinical literature. As a result, questions about absorption, distribution, metabolism, excretion, and long-term safety are unresolved. Discussions often appear in nootropic forums, where anecdotal reports cannot substitute for controlled trials. Researchers have called for more rigorous pharmacokinetic and toxicological studies before any clinical evaluation. Until such data exist, dihexa is best described as an investigational research compound rather than a proven intervention.
The proposed mechanism for dihexa centers on hepatocyte growth factor, or HGF, and its receptor c-Met. HGF signaling is involved in cell growth, survival, and synapse formation. Dihexa has been described as an HGF mimetic or modulator in preclinical literature. Whether it binds c-Met directly, increases HGF availability, or acts through another route remains uncertain. This mechanistic uncertainty is a recurring theme in reviews of the compound, and no single molecular model has been confirmed across independent laboratories.
Dihexa is a synthetic peptide studied in laboratory research. It is often described as an angiotensin IV analog or a hepatocyte growth factor mimetic. The compound emerged from investigations into angiotensin IV and its effects on neural pathways. It is not an approved medication, and controlled human trials are lacking. In literature and online forums, it is discussed mainly as a research chemical. Its chemical name appears as N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) in some sources.
Development of dihexa has been linked to academic research on synaptogenesis, the formation of new synapses. Preclinical studies in rodents have examined its effects on learning and memory tasks. These studies are often cited in discussions about cognitive enhancement, but they do not establish safety or efficacy in humans. The compound's patent and commercial history is limited, and it is not widely available through pharmaceutical channels. Most information comes from animal models and in vitro experiments. Researchers continue to explore its basic biology rather than clinical applications.
| Property | Value | Notes |
|---|---|---|
| Primary proposed target | HGF/c-Met signaling | Direct binding not confirmed |
| Research models | Rodent and cell studies | Preclinical only |
| Human clinical data | None published | Safety and efficacy unknown |
| Regulatory status | Unapproved research chemical | Status varies by country |
| Typical research purity | 95% or higher by HPLC | Depends on supplier and batch |
Identity and purity are usually assessed with reverse-phase high-performance liquid chromatography and mass spectrometry. These methods can separate related impurities and confirm molecular mass, but they do not by themselves establish biological activity. Certificate of analysis documents may report purity as a percentage by area, yet the exact meaning can vary between laboratories. Independent testing can check for residual solvents, counterions, or microbial contamination when relevant. For research use, matching analytical records to a specific lot helps trace experimental variability.
Dihexa occupies an uncertain regulatory space in many countries. It is not generally listed as an approved therapeutic, and some jurisdictions may treat it as a research chemical, a compounded substance, or an unapproved new drug depending on claims and distribution. Importation can be restricted, and suppliers may require documentation that the material is for laboratory research only. Quality and labeling vary, so buyers should request analytical data, verify lot numbers, and understand local rules. These factors make sourcing and compliance part of the practical context around dihexa.
Lyophilized dihexa is typically stored as a dry powder at or below minus twenty degrees Celsius. Cooler temperatures slow degradation, and desiccant protection limits moisture uptake. Repeated temperature cycling can accelerate breakdown, so aliquoting before storage is common in laboratory practice. Solutions are generally less stable than dry powder and are often kept cold, protected from light, and used within a defined period. Specific stability data for dihexa are limited, and handling recommendations often follow general peptide guidelines rather than compound-specific studies.
Dihexa is a synthetic compound studied in laboratory and animal models for effects on synaptic connectivity and cognitive performance. It is often described as a peptide analog because its structure incorporates amino acid residues linked to a hexanoic acid group. The molecule is not a naturally occurring human hormone or neurotransmitter. Its name appears in research literature and online discussions, but it has not been approved as a medicine by major regulatory agencies. Most information comes from preclinical experiments rather than controlled human trials.
The compound originated from work on angiotensin IV, a peptide fragment of the renin-angiotensin system. Researchers modified angiotensin IV-related structures to produce molecules with altered stability and activity. Dihexa emerged from that effort and was reported to promote dendritic spine growth in cultured neurons. Some studies link its effects to hepatocyte growth factor signaling and the c-Met receptor, while other work points to insulin-regulated aminopeptidase. The precise primary target remains a subject of investigation, and findings may depend on cell type, assay conditions, and species.
In animal research, dihexa has been administered through several routes, and reports describe improved performance on spatial learning and memory tasks in rodents. These results are frequently cited in discussions of nootropic compounds. However, species differences, small sample sizes, and varied testing protocols limit how far the findings can be generalized. No large randomized controlled trials in humans have established efficacy or long-term safety. Claims about human cognitive enhancement therefore remain speculative, and the compound is best described as an experimental laboratory substance rather than a proven therapeutic or supplement.
Dihexa is typically supplied as a lyophilized powder for laboratory research. Lyophilization removes water and improves stability during transport and storage. The solid is commonly stored at -20 °C or lower, desiccated, and protected from light. Repeated freeze-thaw cycles and exposure to moisture can degrade peptides, so aliquoting and sealed containers are standard practice in most laboratory settings. These handling measures apply to research-grade material and do not imply clinical suitability.
Purity and identity are usually assessed with reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry. RP-HPLC separates components by hydrophobicity and can estimate peptide purity. Mass spectrometry confirms molecular mass and helps detect truncations or modifications. Some laboratories also use amino acid analysis or nuclear magnetic resonance for structural verification. A certificate of analysis from a supplier may list these results, but independent verification is often recommended for critical work.
Regulatory status varies by country, and dihexa is not widely approved as a medicine. In many jurisdictions it is treated as a research chemical, which limits its legal sale, possession, and human use. Products marketed online may lack verified purity or identity, and labels can be inaccurate. Researchers typically source material from suppliers that provide analytical documentation and follow institutional safety rules. Open questions remain about long-term stability, metabolite formation, and human pharmacokinetics.
Most published reports on dihexa come from cell cultures and animal models. Studies have examined markers of synapse formation, dendritic spine density, and performance on learning tasks in rodents. Proposed mechanisms center on hepatocyte growth factor and its c-Met receptor, with additional attention to angiotensin IV-related pathways. These findings are experimental and have not been confirmed as clinical benefits in humans. The literature often uses different tasks and endpoints, which complicates direct comparison across studies.
Regulatory status differs by country, but dihexa is generally not approved as a therapeutic product. It is often sold as a research chemical, which means purity, labeling, and handling fall outside pharmaceutical drug standards. Some jurisdictions restrict the sale of peptides intended for human consumption. Researchers and suppliers may therefore face different legal requirements depending on location. Import rules and customs enforcement can also affect how such compounds move across borders.
The HA-tag is a protein tag derived from the human influenza hemagglutinin (HA) protein, which allows the virus to target and enter host cells. An HA-tag is composed of a peptide derived from the HA-molecule corresponding to amino acids 98-106, which can be recognized and selectively bound by commercially available antibodies. This makes HA a powerful tool in molecular biology, commonly included in expression vectors and in the production of recombinant proteins. Like other epitope tags, HA-tag is small and generally does not alter the traits of proteins it is attached to. As a result HA-tags are often used to identify protein-protein interactions or to detect protein expression, using Co-Immunoprecipitation or Western blot respectively. The HA-tag is not suitable for detection or purification of proteins from apoptotic cells since it is cleaved by Caspase-3 and / or Caspase-7 after its sequence DVPD, causing it to lose its immunoreactivity. Labeling of endogenous proteins with HA-tag using CRISPR was recently accomplished in-vivo in differentiated neurons.
On July 13, 2024, Trump survived an assassination attempt while addressing a campaign rally near Butler, Pennsylvania. Trump was shot and wounded on his right ear by 20-year-old Thomas Crooks, who fired eight rounds with an AR-15–style rifle from the roof of a building approximately 400 feet (120 metres) from the stage; the shots killed one audience member and critically injured two others. Seconds later, Crooks was shot and killed by the U.S. Secret Service's counter-sniper team. On September 11, 2024, a bipartisan Senate report identified technical issues and other preventable mistakes by the Secret Service during the event. On September 15, 2024, Trump survived a second assassination attempt at Trump International Golf Club in West Palm Beach, Florida. The perpetrator, 58-year-old Ryan Wesley Routh, took position in nearby shrubbery holding an SKS-style rifle just outside the fence of the golf course. After hiding there for nearly 12 hours, Routh pointed his weapon through the fence line, approximately 400 yards (370 m) away from Trump. A Secret Service agent noticed this and fired four rounds towards Routh, who fled the scene and was later captured in Martin County. No injuries were reported. Routh was later indicted on five federal charges and three state charges, all of which Routh pleaded not guilty to. His trial began on September 8, 2025. Two weeks later on September 23, Routh was found guilty on all federal counts, where he then grabbed a pen and attempted to stab himself in the neck, before being tackled by U.S. marshals.
==== Biomarkers of cereal presence in archaeological pottery ==== Recently, alkylresorcinols have been widely recognised as a biomarker for the presence of cereals in archaeological pottery. They were previously found in a well-preserved Bronze Age wooden container from Switzerland, and coarse ware vessels from a Roman cavalry barrack at Vindolanda. A study demonstrated that the survival of ARs is highly dependent on the cooking procedures and burial conditions. However, if recoverable, analysis of these phenolic lipids in archaeological contexts is valuable as it can help explain the uptake and spread of cereal processing of past communities in particular regions.
Sources: en.wikipedia.org
In The Hill's article The Hill's Latina Leaders to Watch, Resident Commissioner González is described as a pro-statehood, small government, pro-business conservative. In the first session of the 115th United States Congress, González was ranked the 19th most bipartisan member of the House by the Bipartisan Index, a metric published by The Lugar Center and Georgetown's McCourt School of Public Policy to assess congressional bipartisanship. In 2019, González was one of three House Republicans, along with Brian Fitzpatrick and John Katko, to co-sponsor the Equality Act, which prohibits discrimination on the basis of sexual orientation and gender identity. Although González could not vote for final passage of the bill due to U.S. House rules, the legislation passed the United States House of Representatives during the 116th Congress. After the 2021 United States Capitol attack, the congresswoman condemned the violence and blamed President Donald Trump for inciting the riot. However, the congresswoman still supported the majority of Republicans in their effort to remove Liz Cheney from her position as chair of House Republican Conference. González said in a letter to U.S. President Donald Trump that Nicolás Maduro "is an open threat to the United States, our national security and stability in the region". Likewise, she has repeatedly affirmed her support for American expansionism, saying in 2025 that "the President's policy is to expand American territory, so he wants to add Canada and Greenland to that expansion.
In 1974, GM offered driver and passenger airbags as optional equipment on large Cadillacs, Buicks, and Oldsmobiles. In 1976, the crash test dummy Hybrid III was introduced to assess the impacts of car collisions. It represented the 50th percentile male standing at approximately 5' 9" tall and weighing 78 kg (171 lbs). In 1979, NHTSA began crash-testing popular cars and publishing the results, to inform consumers and encourage manufacturers to improve the safety of their vehicles. Initially, the US NCAP (New Car Assessment Program) crash tests examined compliance with the occupant-protection provisions of FMVSS 208. Over the subsequent years, this NHTSA program was gradually expanded in scope.
== Distribution == The labeled [18F]FDG compound has a relatively short shelf life which is determined largely by the physical decay of fluorine-18 with a half-life of 109.8 minutes, or slightly less than two hours. Still, this half-life is sufficiently long to allow shipping the compound to remote PET scanning facilities, in contrast to other medical radioisotopes like carbon-11 with a half-life of ~20 minutes. Due to transport regulations for radioactive compounds, delivery is normally done by specially licensed road transport, but means of transport may also include dedicated small commercial jet services. Transport by air allows expanding the distribution area around a [18F]FDG production site to deliver the compound to PET scanning centres within a 1–3-hour flight time. Recently, on-site cyclotrons with integral shielding and portable chemistry stations for making [18F]FDG have accompanied PET scanners to remote hospitals. This technology holds some promise in the future, for replacing some of the scramble to transport [18F]FDG from site of manufacture to site of use.
==== Clean vehicle and clean energy home improvement tax credits eliminated ==== The tax credit for buying a new qualified electric vehicle or fuel cell electric vehicle is no longer available for purchases made after September 30, 2025. The tax credit for buying a used qualified electric vehicle or fuel cell vehicle from a licensed dealer is no longer available for purchases made after September 30, 2025. The tax credit for installing property to either recharge electric vehicles or to store or dispense clean-burning fuel will no longer be available after June 30, 2026. The tax credit for making qualified energy-efficient improvements to one's home will no longer be available for improvements put into service after December 31, 2025. The tax credit for installing solar electric panels, solar water heaters, wind turbines, geothermal heat pumps, fuel cells, or battery storage technology in one's home will no longer be available for improvements made after December 31, 2025.
Sources: en.wikipedia.org
== Physiology == Proprioception is mediated by mechanically sensitive proprioceptor neurons distributed throughout an animal's body. Most vertebrates possess three basic types of proprioceptors: muscle spindles, which are embedded in skeletal muscles, Golgi tendon organs, which lie at the interface of muscles and tendons, and joint receptors, which are low-threshold mechanoreceptors embedded in joint capsules. Many invertebrates, such as insects, also possess three basic proprioceptor types with analogous functional properties: chordotonal neurons, campaniform sensilla, and hair plates. The initiation of proprioception is the activation of a proprioceptor in the periphery. The proprioceptive sense is believed to be composed of information from sensory neurons located in the inner ear (motion and orientation) and in the stretch receptors located in the muscles and the joint-supporting ligaments (stance). There are specific nerve receptors for this form of perception termed "proprioceptors", just as there are specific receptors for pressure, light, temperature, sound, and other sensory experiences. Members of the transient receptor potential family of ion channels have been found to be important for proprioception in fruit flies, nematode worms, African clawed frogs, and zebrafish. PIEZO2, a nonselective cation channel, has been shown to underlie the mechanosensitivity of proprioceptors in mice.
== Early life == Arsène Charles Ernest Wenger was born on 22 October 1949 in Strasbourg, Bas-Rhin, the youngest of three children born to Alphonse and Louise Wenger. He lived in Duppigheim during the 1950s, but spent most of his time in the neighbouring village of Duttlenheim, 16 km (10 miles) south-west of Strasbourg. Arsène's father, Alphonse, like many Alsatians, was conscripted into the German Army by force following Germany's earlier annexation of the French region of Alsace-Lorraine. He was sent to fight on the Eastern Front in October 1944, at the age of 24. The Wenger family owned an automobile spare parts business and a bistro named La Croix d'Or. In his book, My Life in Red and White, Wenger says the "alcohol, brawling and violence" of the bistro's patrons sparked his early interest in human psychology. His parents had difficulty looking after their children, but Duttlenheim was a village where everyone took care of the young; Wenger compared it in later years to a kibbutz. Before Wenger started school, he expressed himself in the local Alsatian dialect of Low Alemannic German. The primary school which Wenger attended was run by the Catholic Church, and as one of its brightest students, he later was accepted into a secondary school in Obernai. According to his father, who also managed the village team, Wenger was introduced to football "at about the age of six". He was taken to games in Germany, where he held an affection for Borussia Mönchengladbach.
== History == The earliest human activity in Ningxia can be traced back to 30,000 years ago, with remains of the Shuidonggou culture found in Lingwu. As a frontier zone between nomadic pastoralists and sedentary farmers, Ningxia was a frequent seat of war and incursions by non-Chinese tribes. Ningxia and its surrounding areas were incorporated into the Qin as the Beidi Commandery as early as the 3rd century BC. To pacify the region, the imperial government established military colonies to reclaim land. In addition, horse pasturages were founded under the Imperial Stud to safeguard the supply of army horses, as early as the Western Han dynasty (206 BC – AD 9). Throughout the Han dynasty and the Tang dynasty there were several large cities established in the region. The Liang Province rebellion at the end of the Han dynasty affected Ningxia. By the 11th century the Tangut people had established the Western Xia dynasty on the outskirts of the then-Song dynasty. Jews also lived in Ningxia, as evidenced by the fact that in 1489, after a major flood destroyed Torah scrolls in Kaifeng, a replacement set was sent to the Kaifeng Jews by the Ningbo and Ningxia Jewish communities. It then came under Mongol domination after Genghis Khan conquered Yinchuan in the early 13th century. Muslims from Central Asia also began moving into Ningxia from the west. By the late 17th century, Ningxia had become a weaving centre, producing many early Chinese carpets. The Muslim Dungan Revolt of the 19th century affected Ningxia. In 1914, Ningxia was merged with the province of Gansu.
Sources: en.wikipedia.org
Dihexa has been proposed to act through HGF and c-Met signaling. This pathway is linked to synapse formation and cellular growth. Direct binding and the precise molecular step remain uncertain.
No published human clinical trials are available for dihexa. Its safety and effectiveness in people are therefore unknown. Most available evidence comes from animal and cell studies.
Preclinical studies often measure dendritic spine density and synaptic protein levels. Behavioral tests include maze learning and avoidance tasks. These endpoints are indirect and do not establish clinical benefit.
Dihexa is a synthetic peptide investigated in preclinical research. It is often classified as an angiotensin IV analog or an HGF mimetic. It is not an approved medicine.